Abstract
Nanotechnology has been extensively exploited for its enormous therapeutic and diagnostic potential in the management of multiple disorders. It employs nanomaterials as drug carriers with enhanced efficacy and limited side effects on normal tissues. A lot of nanomaterials have been studied and produced, imminently reforming the treatment and diagnostics of numerous malignancies, including cancer. The purpose of the present study is to explore the role of nanotechnology-based devices/therapies that have a vital function in the therapeutics and diagnostics of cancer with potential impact at three levels: early detection, tumor imaging, and drug delivery methods. Concentrating on cancer, promising nanotechnology-based approaches have been planned to satisfy the need for targeted specificity of traditional agents of chemotherapeutics, in addition to early recognition of malignant and precancerous lesions. Prostate cancer is the fifth most wellknown cancer worldwide and the second most usually detected cancer in men. Therefore, there is a crucial need to improve therapeutic prospects for the diagnosis and treatment of prostate cancer via the exploitation of the potential of nanomaterials for cell-targeted specificity and improved primary diagnosis of precancerous tumors. The present review, therefore, focuses on summarizing all prospective applications of nanotechnology in the prognosis and diagnosis of prostate cancer, which would further help researchers to elucidate a more potent therapeutic approach for the better management of prostate cancer in the days ahead.
Keywords: Cancer cell, prostate cancer, cytotoxicity, nanoparticles, targeted delivery, drug delivery.
Current Medicinal Chemistry
Title:Nanoparticles Mediated Target-specific Drug Delivery in Prostate Cancer: An In-depth Review
Volume: 29 Issue: 24
Author(s): Tarun Kumar Upadhyay*, Mohammed Irfan Ali, Fahad Khan, Harsh Goel, Manas Mathur, Keshav Goyal, Sarmad Moin, Pratibha Pandey, Pranay Tanwar, Amit Baran Sharangi, Saloni Dinesh Chandra Gautam, Jhanvi Kiran Kapdi, Kruti Indravadan Patel, Meghna Vipulbhai Patel, Amisha M. Parmar and Mohammad Amjad Kamal
Affiliation:
- Department of Biotechnology, Animal Cell Culture and Immunobiochemistry Lab, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara, Gujarat, 391760, India
Keywords: Cancer cell, prostate cancer, cytotoxicity, nanoparticles, targeted delivery, drug delivery.
Abstract: Nanotechnology has been extensively exploited for its enormous therapeutic and diagnostic potential in the management of multiple disorders. It employs nanomaterials as drug carriers with enhanced efficacy and limited side effects on normal tissues. A lot of nanomaterials have been studied and produced, imminently reforming the treatment and diagnostics of numerous malignancies, including cancer. The purpose of the present study is to explore the role of nanotechnology-based devices/therapies that have a vital function in the therapeutics and diagnostics of cancer with potential impact at three levels: early detection, tumor imaging, and drug delivery methods. Concentrating on cancer, promising nanotechnology-based approaches have been planned to satisfy the need for targeted specificity of traditional agents of chemotherapeutics, in addition to early recognition of malignant and precancerous lesions. Prostate cancer is the fifth most wellknown cancer worldwide and the second most usually detected cancer in men. Therefore, there is a crucial need to improve therapeutic prospects for the diagnosis and treatment of prostate cancer via the exploitation of the potential of nanomaterials for cell-targeted specificity and improved primary diagnosis of precancerous tumors. The present review, therefore, focuses on summarizing all prospective applications of nanotechnology in the prognosis and diagnosis of prostate cancer, which would further help researchers to elucidate a more potent therapeutic approach for the better management of prostate cancer in the days ahead.
Export Options
About this article
Cite this article as:
Upadhyay Kumar Tarun *, Ali Irfan Mohammed , Khan Fahad , Goel Harsh, Mathur Manas, Goyal Keshav, Moin Sarmad , Pandey Pratibha, Tanwar Pranay , Sharangi Baran Amit, Gautam Dinesh Chandra Saloni, Kapdi Kiran Jhanvi, Patel Indravadan Kruti , Patel Vipulbhai Meghna , Parmar M. Amisha and Kamal Amjad Mohammad, Nanoparticles Mediated Target-specific Drug Delivery in Prostate Cancer: An In-depth Review, Current Medicinal Chemistry 2022; 29 (24) . https://dx.doi.org/10.2174/0929867329666211221112312
DOI https://dx.doi.org/10.2174/0929867329666211221112312 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Doping and Genetic Testing: Sex Difference in UGT2B15 Expression, Testosterone Glucuronidation Activity and Urinary Testosterone/ Epitestosterone Glucuronide Ratio
Current Pharmacogenomics and Personalized Medicine Applications of Mannich Reaction in Total Syntheses of Natural Products
Current Organic Chemistry Quantitative Analysis and Pharmacokinetics Study of Integrin Antagonist AP25 in Rat Plasma
Protein & Peptide Letters Synthesis, Antioxidant and Antitumor Activity of Some Substituted 9-Anilinoacridine and 4-Anilinoquinolines Derivatives
Current Organic Synthesis Clinical Evaluation of Anti-Obesity Drugs
Current Drug Targets Calixarene HPLC Phases - Applications
Current Analytical Chemistry Angiogenesis in Chronic Lymphocytic Leukemia
Current Angiogenesis (Discontinued) Protein Microarrays for Studies of Drug Mechanisms and Biomarker Discovery in the Era of Systems Biology
Current Pharmaceutical Design Gold Nanomaterials: From Preparation to Pharmaceutical Design and Application
Current Pharmaceutical Design DDX39B Predicts Poor Survival and Associated with Clinical Benefit of Anti-PD-L1 Therapy in ccRCC
Current Cancer Drug Targets Competitive Interaction Between Plasma Omega-3 Fatty Acids and Arachidonic Acid is Related to Down-Regulation of A Signaling Mediator
Medicinal Chemistry Meta Analysis of Advanced Cancer Survival Data Using Lognormal Parametric Fitting: A Statistical Method to Identify Effective Treatment Protocols
Current Pharmaceutical Design Gene-Nutrient Interaction in Type 2 Diabetes: An Appraisal of the Role of the Peroxisome Proliferator-Activated Receptor Pathway
Current Pharmacogenomics Enantioresolution of Chiral Derivatives of Xanthones on Different Types of Liquid Chromatography Stationary Phases: A Comparative Study
Current Chromatography Design, Synthesis, and In vitro Antitumor Evaluation of Novel Phenylaminopyrimidine Derivatives
Medicinal Chemistry Synthesis of Coumarin linked Naphthalimide Conjugates as Potential Anticancer and Antimicrobial Agents
Letters in Drug Design & Discovery Potential Role of Bioactive Lipids in Rheumatoid Arthritis
Current Pharmaceutical Design Isoprenoid Metabolism as a Therapeutic Target in Gram-Negative Pathogens
Current Topics in Medicinal Chemistry β-Synuclein Assembly as a Therapeutic Target of Parkinsons Disease and Related Disorders
Current Pharmaceutical Design Tropical Ginger Extract as Protectant in Radiation Countermeasures
Current Traditional Medicine